So we got your inquiry about the LY3298176 variant—what you'll mostly see it doing these days is driving research into dual-receptor activation for metabolic pathways, especially where single agonists fall short on glucose control or weight regulation, and the 99% HPLC purity means you're not chasing impurities through your assays.
That CAS number 2023788-19-2 comes through as a in the 10mg per vial format, and honestly we've shipped dozens of these to labs running type 2 diabetes studies or obesity models, though it's not really suited for acute toxicity screens unless you're ready to adjust dosing protocols.

Molecular weight is 4813.5 g/mol, and the storage is straightforward—just keep it at -20°C away form light and moisture, or you'll lose activity faster than you'd expect, and we usually have stock but confirm lead time if you need more than 50 vials or so.

Most buyers go with pharmaceutical grade precisely because of that dual GIP and GLP-1 agonist profile—teh tighter tolerance on purity compared to reagent grade matters when you're looking at dose-response consistency across multiple treatment groups, and we're talking roughly 2-4 weeks for standerd orders (check lead time on bulk quantities).
It basically activates both receptors at once unlike some earlier peptides that only hit one, so for your energy homeostasis or metabolic disorder studies this gives you a cleaner read on pathway crosstalk—anyway, we keep a COA on file for each lot if you need to verify that ≥99% spec before you commit to a full run.